Findex: Supplementary Information on Q3FY2024 Quarterly Business Results Summary
Findex: Consolidated Financial Results_2024Q3_Findex
Findex: Presentation material for the second quarter of fiscal year 2024.
Findex: Consolidated financial results for the second quarter of 2024, FinDex.
Findex: Announcements of individual stocks regarding the revision of financial estimates for the second quarter of the fiscal year ending on December 31, 2024.
Findex: Announcements of individual stocks regarding provisional results on product implementation.
Findex: Announcements of individual stocks regarding the introduction results report by product.
Findex: Announcements of individual stocks: The clinical ophthalmology eye field analysis type visual field measuring instrument 'GAP' will be featured in the July 2024 issue.
Findex: Start providing “CocktailAI,” a sentence generation solution for medical documents using generative AI
Findex: Paper presentation on the gaze analysis type field meter “GAP” developed in-house and our future efforts
Findex: Supplementary information on financial results summary for the 1st quarter of fiscal year 2024
Findex: Consolidated Financial Results_Q1 2024 _ Findex
Findex: Medical certificate and other document preparation service “DocumMaker Cloud” released
Fine Index: Notice regarding completion of payment of treasury stock disposal as share compensation with transfer restrictions
Findex: Corporate Governance Report
Fine Index: Notice regarding disposal of treasury stock as share compensation with transfer restrictions
Findex: Notice regarding the acquisition of “Kurumin Certification”
Fine Index: Notice of meeting the Prime Market segment's continuing listing criteria
Fine Index: Notice Concerning Compliance with Prime Market Listing Maintenance Standards
Findex: Presentation Material for FY2023 Business Results